According to Profound Medical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 28.1311. At the end of 2023 the company had a P/S ratio of 25.2.
Year | P/S ratio | Change |
---|---|---|
2023 | 25.2 | -24.51% |
2022 | 33.4 | -1.27% |
2021 | 33.8 | -51.74% |
2020 | 70.1 | 68.09% |
2019 | 41.7 | 36.34% |
2018 | 30.6 | 88.58% |
2017 | 16.2 | |
2016 | N/A |